The human papillomavirus type 11 and 16 E 6 proteins modulate the cell-cycle regulator and transcription cofactor TRIP-Br 1

The genital human papillomaviruses (HPVs) are a taxonomic group including HPV types that preferentially cause genital and laryngeal warts (“low-risk types”), such as HPV-6 and HPV-11, or cancer of the cervix and its precursor lesions (“high-risk types”), such as HPV-16. The transforming processes induced by these viruses depend on the proteins E5, E6, and E7. Among these oncoproteins, the E6 protein stands out because it supports a particularly large number of functions and interactions with cellular proteins, some of which are specific for the carcinogenic HPVs, while others are shared among lowand high-risk HPVs. Here we report yeast two-hybrid screens with HPV-6 and -11 E6 proteins that identified TRIP-Br1 as a novel cellular target. TRIP-Br1 was recently detected by two research groups, which described two separate functions, namely that of a transcriptional integrator of the E2F1/DP1/RB cell-cycle regulatory pathway (and then named TRIP-Br1), and that of an antagonist of the cyclin-dependent kinase suppression of p16INK4a (and then named p34SEI-1). We observed that TRIP-Br1 interacts with lowand high-risk HPV E6 proteins in yeast, in vitro and in mammalian cell cultures. Transcription activation of a complex consisting of E2F1, DP1, and TRIP-Br1 was efficiently stimulated by both E6 proteins. TRIP-Br1 has an LLG E6 interaction motif, which contributed to the binding of E6 proteins. Apparently, E6 does not promote degradation of TRIP-Br1. Our observations imply that the cell-cycle promoting transcription factor E2F1/DP1 is dually targeted by HPV oncoproteins, namely (i) by interference of the E7 protein with repression by RB, and (ii) by the transcriptional cofactor function of the E6 protein. Our data reveal the natural context of the transcription activator function of E6, which has been predicted without knowledge of the E2F1/DP1/TRIP-Br/E6 complex by studying chimeric constructs, and add a function to the limited number of transforming properties shared by lowand high-risk HPVs. © 2003 Elsevier Inc. All rights reserved.

• Publication year

  2003

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Transcription: Sibling rivalry in the E2F family

  2002cited by this paper
• Interaction of Zyxin, a Focal Adhesion Protein, with the E6 Protein from Human Papillomavirus Type 6 Results in Its Nuclear Translocation

  2001cited by this paper
• E Box-Dependent Activation of Telomerase by Human Papillomavirus Type 16 E6 Does Not Require Induction of c-myc

  2001cited by this paper
• TRIP‐Br: a novel family of PHD zinc finger‐ and bromodomain‐interacting proteins that regulate the transcriptional activity of E2F‐1/DP‐1

  2001influential reference
• The Human Papillomavirus E6 protein and its contribution to malignant progression

  2001influential reference
• Biological activities and molecular targets of the human papillomavirus E7 oncoprotein

  2001cited by this paper
• Gps2, a Protein Partner for Human Papillomavirus E6 Proteins

  2001cited by this paper
• Identification of a Second Transforming Function in Bovine Papillomavirus Type 1 E6 and the Role of E6 Interactions with Paxillin, E6BP, and E6AP

  2000cited by this paper
• Human papillomavirus types 16 E6 and E7 contribute differently to carcinogenesis.

  2000cited by this paper
• The Human Papillomavirus Type 16 E6 Oncoprotein Can Down-Regulate p53 Activity by Targeting the Transcriptional Coactivator CBP/p300

  1999influential reference
• The E6 protein of human papillomavirus type 16 binds to and inhibits co‐activation by CBP and p300

  1999cited by this paper
• Regulation of CDK4 activity by a novel CDK4-binding protein, p34(SEI-1).

  1999influential reference
• Identification of an α Helical Motif Sufficient for Association with Papillomavirus E6*

  1998cited by this paper
• The regulation of E2F by pRB-family proteins.

  1998cited by this paper
• Association of Bovine Papillomavirus Type 1 E6 oncoprotein with the focal adhesion protein paxillin through a conserved protein interaction motif

  1998cited by this paper
• Human papillomavirus 16 E6 oncoprotein binds to interferon regulatory factor-3 and inhibits its transcriptional activity.

  1998cited by this paper
• E3-Ubiquitin Ligase/E6-AP Links Multicopy Maintenance Protein 7 to the Ubiquitination Pathway by a Novel Motif, the L2G Box*

  1998cited by this paper
• Human papillomavirus oncoprotein E6 binds to the C-terminal region of human minichromosome maintenance 7 protein.

  1998cited by this paper
• Transformation by bovine papillomavirus type 1 E6 is independent of transcriptional activation by E6

  1997cited by this paper
• Binding of high-risk human papillomavirus E6 oncoproteins to the human homologue of the Drosophila discs large tumor suppressor protein.

  1997cited by this paper
• Binding of human virus oncoproteins to hDlg/SAP97, a mammalian homolog of the Drosophila discs large tumor suppressor protein.

  1997cited by this paper
• Inhibition of cyclin D-CDK4/CDK6 activity is associated with an E2F-mediated induction of cyclin kinase inhibitor activity.

  1996cited by this paper
• Predicted alpha-helix/beta-sheet secondary structures for the zinc-binding motifs of human papillomavirus E7 and E6 proteins by consensus prediction averaging and spectroscopic studies of E7.

  1996cited by this paper
• Papillomavirus infections--a major cause of human cancers.

  1996cited by this paper
• Analysis of genomic sequences of 95 papillomavirus types: uniting typing, phylogeny, and taxonomy

  1995influential reference
• Localization of the E6-AP regions that direct human papillomavirus E6 binding, association with p53, and ubiquitination of associated proteins

  1993cited by this paper
• The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53.

  1993cited by this paper
• Transcriptional activation of several heterologous promoters by the E6 protein of human papillomavirus type 16

  1992influential reference
• Cloning, expression, and transcriptional properties of the human enhancer factor TEF-1.

  1991cited by this paper
• The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53.

  1990cited by this paper
• Transcriptional activation by the papillomavirus E6 zinc finger oncoprotein.

  1990influential reference
• Association of human papillomavirus types 16 and 18 E6 proteins with p53.

  1990cited by this paper

• Increase of the T-reg-recruiting chemokine CCL22 expression in a progressive course of cervical dysplasia

  2023cites this paper
• Role of FoxP3-positive regulatory T-cells in regressive and progressive cervical dysplasia

  2021cites this paper
• Regulation of LCoR and RIP140 expression in cervical intraepithelial neoplasia and correlation with CIN progression and dedifferentiation

  2020cites this paper
• The involvement of E6, p53, p16, MDM2 and Gal-3 in the clinical outcome of patients with cervical cancer

  2017cites this paper
• Investigation of RIP140 and LCoR as independent markers for poor prognosis in cervical cancer

  2017cites this paper
• Sterile α Motif Domain Containing 9 Is a Novel Cellular Interacting Partner to Low-Risk Type Human Papillomavirus E6 Proteins

  2016cites this paper
• Role of Cdk 1 in the p 53-Independent Abrogation of the Postmitotic Checkpoint by Human Papillomavirus E 6

  2015cites this paper
• Overexpression of SERTAD3, a putative oncogene located within the 19q13 amplicon, induces E2F activity and promotes tumor growth

  2007cites this paper
• Detection of Human Papillomavirus and Relevant Tumor Suppressors and Oncoproteins in Laryngeal Tumors

  2006cites this paper